These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35234630)
1. Cryo-EM structure of glycoprotein C from Crimean-Congo hemorrhagic fever virus. Li N; Rao G; Li Z; Yin J; Chong T; Tian K; Fu Y; Cao S Virol Sin; 2022 Feb; 37(1):127-137. PubMed ID: 35234630 [TBL] [Abstract][Full Text] [Related]
2. Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean-Congo hemorrhagic fever virus. Li L; Chong T; Peng L; Liu Y; Rao G; Fu Y; Shu Y; Shen J; Xiao Q; Liu J; Li J; Deng F; Yan B; Hu Z; Cao S; Wang M PLoS Pathog; 2024 Feb; 20(2):e1011948. PubMed ID: 38300972 [TBL] [Abstract][Full Text] [Related]
3. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus. Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038 [TBL] [Abstract][Full Text] [Related]
6. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A J Virol; 2017 May; 91(10):. PubMed ID: 28250124 [TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1. Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside-Modified mRNA Vaccines Protect IFNAR Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199 [TBL] [Abstract][Full Text] [Related]
9. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies. Mishra AK; Hellert J; Freitas N; Guardado-Calvo P; Haouz A; Fels JM; Maurer DP; Abelson DM; Bornholdt ZA; Walker LM; Chandran K; Cosset FL; McLellan JS; Rey FA Science; 2022 Jan; 375(6576):104-109. PubMed ID: 34793197 [TBL] [Abstract][Full Text] [Related]
11. LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus. Xu ZS; Du WT; Wang SY; Wang MY; Yang YN; Li YH; Li ZQ; Zhao LX; Yang Y; Luo WW; Wang YY Cell Res; 2024 Feb; 34(2):140-150. PubMed ID: 38182887 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus. Mears MC; Rodriguez SE; Schmitz KS; Padilla A; Biswas S; Cajimat MNB; Mire CE; Welch SR; Bergeron É; Alabi CA; Porotto M; Bente DA Antiviral Res; 2022 Nov; 207():105401. PubMed ID: 36049554 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Crimean-Congo Hemorrhagic Fever Virus and Aigai Virus in Life Cycle Modeling Systems Reveals a Difference in L Protein Activity. Pickin MJ; Devignot S; Weber F; Groschup MH J Virol; 2022 Jul; 96(13):e0059922. PubMed ID: 35695578 [TBL] [Abstract][Full Text] [Related]
14. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies. Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome profiling highlights regulated biological processes and type III interferon antiviral responses upon Crimean-Congo hemorrhagic fever virus infection. Mo Q; Feng K; Dai S; Wu Q; Zhang Z; Ali A; Deng F; Wang H; Ning YJ Virol Sin; 2023 Feb; 38(1):34-46. PubMed ID: 36075566 [TBL] [Abstract][Full Text] [Related]
16. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015. Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670 [TBL] [Abstract][Full Text] [Related]
17. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models. Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305 [TBL] [Abstract][Full Text] [Related]